2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride

C20H22ClN3O2 — CID 119387578

IUPAC2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride
SMILESCl.O=C(Cn1c2ccccc2c(=O)c2ccccc21)NC1CCNCC1
InChIInChI=1S/C20H21N3O2.ClH/c24-19(22-14-9-11-21-12-10-14)13-23-17-7-3-1-5-15(17)20(25)16-6-2-4-8-18(16)23;/h1-8,14,21H,9-13H2,(H,22,24);1H
InChIKeyCGNOLYWEALSRFP-UHFFFAOYSA-N
MW371.87 g/mol
LogP2.44
Rot. Bonds3

About 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride

2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride (PubChem CID 119387578) has the molecular formula C20H22ClN3O2 and a molecular weight of 371.87 g/mol. Its IUPAC name is 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride.

Molecular Properties

Compound Name2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride
PubChem CID119387578
Molecular FormulaC20H22ClN3O2
Molecular Weight371.87 g/mol
Exact Mass371.14
IUPAC Name2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride
SMILESCl.O=C(Cn1c2ccccc2c(=O)c2ccccc21)NC1CCNCC1
InChIInChI=1S/C20H21N3O2.ClH/c24-19(22-14-9-11-21-12-10-14)13-23-17-7-3-1-5-15(17)20(25)16-6-2-4-8-18(16)23;/h1-8,14,21H,9-13H2,(H,22,24);1H
InChIKeyCGNOLYWEALSRFP-UHFFFAOYSA-N
XLogP2.44
TPSA63.13 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds3
Heavy Atoms26
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500371.87
LogP ≤ 52.44
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(9-oxoacridin-10-yl)-N-(6-oxopiperidin-3-yl)acetamide
CID 60616940
2-(2-oxo-3H-benzimidazol-1-yl)-N-pyrrolidin-3-ylacetamide
CID 119453931
N-[2-(aminomethyl)cyclohexyl]-2-(9-oxoacridin-10-yl)acetamide;hydrochloride
CID 119610481
N-cyclopropyl-4-[[2-(9-oxoacridin-10-yl)acetyl]amino]benzamide
CID 26053126
N-[(1S,4R)-4-(hydroxymethyl)cyclopent-2-en-1-yl]-2-(9-oxoacridin-10-yl)acetamide
CID 111661798
N-[(1S,2S,3R)-2,3-dimethylcyclohexyl]-2-(9-oxoacridin-10-yl)acetamide
CID 98750987
3-(3-methyl-2-oxobenzimidazol-1-yl)-N-piperidin-4-ylpropanamide
CID 119388164
N-(2-amino-1-cyclohexylethyl)-2-(9-oxoacridin-10-yl)acetamide;hydrochloride
CID 119590242
2-phenyl-N-piperidin-4-ylacetamide
CID 1445168
10-[2-oxo-2-(3-piperazin-1-ylpyrrolidin-1-yl)ethyl]acridin-9-one;hydrochloride
CID 120996346
N-cyclooctyl-2-(3-ethyl-2,4-dioxoquinazolin-1-yl)acetamide
CID 22110617
N-cyclopropyl-2-(3-ethyl-2-oxobenzimidazol-1-yl)acetamide
CID 17445359

Frequently Asked Questions

What is the IUPAC name of 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride?
The IUPAC name of 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride (CID 119387578) is 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride.
What is the SMILES notation for 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride?
The canonical SMILES for 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride is Cl.O=C(Cn1c2ccccc2c(=O)c2ccccc21)NC1CCNCC1.
What is the InChIKey of 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride?
The InChIKey is CGNOLYWEALSRFP-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H21N3O2.ClH/c24-19(22-14-9-11-21-12-10-14)13-23-17-7-3-1-5-15(17)20(25)16-6-2-4-8-18(16)23;/h1-8,14,21H,9-13H2,(H,22,24);1H.
What are the key properties of 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride?
2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride has a molecular weight of 371.87 g/mol, XLogP of 2.44, 3 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(9-oxoacridin-10-yl)-N-piperidin-4-ylacetamide;hydrochloride is sourced from PubChem (CID 119387578), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).